Subsequent studies have confirmed the HALP score as a useful prognostic tool for predicting the prognosis of patients with various cancer types, including pancreatic and biliary tract cancer (17, 18), lung cancer (19, 20), and urologic cancers such as renal cell carcinoma (21, 22). This evidence concerns the gene NAT10 and renal cell carcinoma.